Abstract
According to the GLOBOCAN / IARC (2012) data, an estimated 1.1 million men worldwide are diagnosed with prostate
cancer annually and 307,000 males die for the same reason. We conducted a descriptive epidemiological study. In 2015-
2016, according to Crude Rate 35 per 100,000 men suffered from prostate cancer annually. ASR-27.3. The rate of prostate cancer sharply increases from the age of 55-59 and reaches peak levels in 75-79 age group (299.3%000 -301.7%000).
Prostate cancer age standardized rate in Tbilisi population was compared with the similar data of European and Asian
cities. According to TASR 225 per 100,000 men at the age of 60-79 years were diagnosed with prostate cancer in 2015-
2016, in Tbilisi. According to TSRR, the incidence of prostate cancer morbidity in the age group of 60-79 is 2.3 times
higher than in the age group of 50-69. According to Relative Frequency, the highest 87.7%000 and 80.9%000 incidence of
prostate cancer is recorded in the age groups of 55-79 and 60-79. Detection of I and II stage prostate cancer in PSA
screening groups is relatively higher (52.6%000). It was established that amendments in the screening guidelines and
monitoring of 60-79 year age group instead of 50-70 years old, will increase the detection of prostate cancer cases by
27.8%. If 50% of target group is involved in the screening program the cost of the program is 289,827, and in case of
70% involvement-it is 405,757.80. Based on the results of the survey, practical recommendations have been developed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2017 Mari Tvaliashvili, Tamar Lobjanidze, Vasil Tkeshelashvili